Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program.
Selmaj KW, Cohen JA, Comi G, Bar-Or A, Arnold DL, Steinman L, Hartung HP, Montalban X, Havrdova EK, Cree BAC, Minton N, Sheffield JK, Ding N, Kappos L.
Selmaj KW, et al. Among authors: minton n.
Mult Scler Relat Disord. 2021 Jun;51:102844. doi: 10.1016/j.msard.2021.102844. Epub 2021 Feb 15.
Mult Scler Relat Disord. 2021.
PMID: 33892317
Free article.